Back

A propensity-matched cohort study on angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers therapy in transthyretin amyloid cardiomyopathy

9 May 2026 (14:30 - 15:30)
Organised by: Logo
Congress Presentation Part of: ePosters in myocardial disease (1) Clinical Delegates Premium Access Heart Failure 2026 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Barbara Lage Garcia

Alto Ave Hospital Center, Guimaraes (Portugal)

7 More presentations in this session

Presentation thumbnail
Non-dilated left ventricular cardiomyopathy at the early stages of chronic chagas disease
Professor R. Bestetti (Ribeirao Preto, BR)
Abstract Slides
Presentation thumbnail
Pre-diagnostic red flags and referral pathways in transthyretin cardiac amyloidosis: correlation with disease stage and outcomes.
Doctor M. Iseppi (Trento, IT)
Abstract Slides
Presentation thumbnail
Device-pocket subcutaneous fat sampling for amyloid screening in elderly patients undergoing cardiac device implantation
Doctor T. Capovilla (Rovereto, IT)
Abstract Slides
Presentation thumbnail
Cardiomyopathy detection using ensemble-based segmentation and radiomics
Doctor T. Tsampras (Athens, GR)
Abstract Slides
Presentation thumbnail
Prognostic value of right ventricular to pulmonary artery coupling in transthyretin amyloid cardiomyopathy
Doctor E. Mata (Creixomil, PT)
Abstract Slides

Access the full session

Session thumbnail
ePosters in myocardial disease (1)

The Event

Event poster

Heart Failure 2026

9 May 2026 14:30 CET

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources